跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOCEHOPE Concentrate for Solution for Infusion 80 mg/ 4 ml - HSA Drug Approval Details
Approvals
/
HSA
/
DOCEHOPE Concentrate for Solution for Infusion 80 mg/ 4 ml
Approved
THERAPEUTIC
DOCEHOPE Concentrate for Solution for Infusion 80 mg/ 4 ml
Glenmark Generics S.A.
🇸🇬 Health Sciences Authority
Approval Date
Feb 7, 2024
Approval ID
a51e52cd9a66270b
Company
Glenmark Generics S.A.
Type
Therapeutic
Approval Details
Approval Id
a51e52cd9a66270b
Drug Name
DOCEHOPE Concentrate for Solution for Infusion 80 mg/ 4 ml
Product Name
DOCEHOPE Concentrate for Solution for Infusion 80 mg/ 4 ml
Approval Number
SIN16942P
Approval Date
2024-02-07
Registrant
GLENMARK PHARMACEUTICALS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01CD02
Atc Item Name
docetaxel
Pharma Manufacturer Name
GLENMARK PHARMACEUTICALS SINGAPORE PTE. LTD.
Company Detail Path
/organization/glenmark-pharmaceuticals-singapore-pte-ltd
Active Ingredients
Docetaxel Anhydrous
80 mg / 4 ml
Docetaxel Anhydrous
80 mg / 4 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 7, 2024
Approval ID
a51e52cd9a66270b
Type
Therapeutic
Back to HSA Approvals
